Phase II trial of Gliadel [carmustine polifeprosan 20 wafer] plus 06-benzylguanine for patients with glioblastoma multiforme
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2013
At a glance
- Drugs Carmustine polifeprosan 20 wafer (Primary) ; Benzylguanine
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 27 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Jul 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2008 The expected completion date for this trial has been identified as Sep 2008, as reported by ClinicalTrials.gov.